This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: H. Lundbeck A/s. Active years: 2010.
Company Filing History:
Years Active: 2010
Title: The Innovations of Tomas Mow
Introduction
Tomas Mow is a notable inventor based in Tureby, Denmark. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of mental health disorders. His work has led to the development of innovative compounds that have the potential to improve the lives of many individuals.
Latest Patents
Tomas Mow holds a patent for a compound known as 4-((1R,3S)-6-Chloro-3-phenylindan-1-yl)-2,2-dimethylpiperazine and its salts. This compound is part of pharmaceutical compositions aimed at treating schizophrenia and other psychotic disorders. His research in this area highlights the importance of developing effective treatments for complex mental health issues.
Career Highlights
Mow is associated with H. Lundbeck A/S, a company renowned for its focus on brain diseases. His role at Lundbeck has allowed him to work on groundbreaking research that contributes to the advancement of psychiatric medicine. His dedication to innovation in this field is evident through his patent and ongoing research efforts.
Collaborations
Throughout his career, Tomas Mow has collaborated with esteemed colleagues such as Benny Bang-Andersen and Klaus P. Bogeso. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further enhancing the quality of research conducted.
Conclusion
Tomas Mow's contributions to pharmaceutical innovation, particularly in the treatment of schizophrenia, underscore the vital role of inventors in advancing medical science. His work continues to inspire future developments in the field.